THE DEAL, AT A GLANCE
From the announcementPathAI
01Who is involvedBacked by General Atlantic, VariousFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedPathAI raised $165M Series CFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersPathAI is using AI pathology to move from cancer diagnosis and drug development support into routine diagnostic pathology through the AISight IVD product.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
PathAI · Financing Record
Explore source-linked visual explanations for PathAI. Unsupported claims are withheld while source review continues.
Record 1010 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →